Szilagyi, J.; Moreira, T.; Nunes, R.S.; Silva, J.; Alves, C.; Martins, A.; Alvariño, R.; Heise, N.V.; Csuk, R.; Xavier, N.M.
5′-Guanidino Xylofuranosyl Nucleosides as Novel Types of 5′-Functionalized Nucleosides with Biological Potential. Pharmaceuticals 2025, 18, 734.
https://doi.org/10.3390/ph18050734
AMA Style
Szilagyi J, Moreira T, Nunes RS, Silva J, Alves C, Martins A, Alvariño R, Heise NV, Csuk R, Xavier NM.
5′-Guanidino Xylofuranosyl Nucleosides as Novel Types of 5′-Functionalized Nucleosides with Biological Potential. Pharmaceuticals. 2025; 18(5):734.
https://doi.org/10.3390/ph18050734
Chicago/Turabian Style
Szilagyi, Jennifer, Tânia Moreira, Rafael Santana Nunes, Joana Silva, Celso Alves, Alice Martins, Rebeca Alvariño, Niels V. Heise, René Csuk, and Nuno M. Xavier.
2025. "5′-Guanidino Xylofuranosyl Nucleosides as Novel Types of 5′-Functionalized Nucleosides with Biological Potential" Pharmaceuticals 18, no. 5: 734.
https://doi.org/10.3390/ph18050734
APA Style
Szilagyi, J., Moreira, T., Nunes, R. S., Silva, J., Alves, C., Martins, A., Alvariño, R., Heise, N. V., Csuk, R., & Xavier, N. M.
(2025). 5′-Guanidino Xylofuranosyl Nucleosides as Novel Types of 5′-Functionalized Nucleosides with Biological Potential. Pharmaceuticals, 18(5), 734.
https://doi.org/10.3390/ph18050734
